From this point, we performed a methylation analysis for CHD1L, and as expected several tumors including UCEC, COAD, PRAD, BLCA, LIHC, HNSC, TGCT, BRCA, and THCA showed hypomethylation in tumor samples versus the normal one. This evidence concerns the gene CHD1L and neoplasm.